Skip to main content
GREEN LIFESCIENCE CO., LTD. logo

GREEN LIFESCIENCE CO., LTD. — Investor Relations & Filings

Ticker · 114450 ISIN · KR7114450000 KO Manufacturing
Open in API
Filings indexed 179 across all filing types
Latest filing 2022-03-08 AGM Information
Country KR South Korea
Listing KO 114450

About GREEN LIFESCIENCE CO., LTD.

https://www.greenlifescience.net/

GREEN LIFESCIENCE CO., LTD. specializes in the development, production, and sale of raw materials and intermediates for various industries. The company's primary offerings include active pharmaceutical ingredients (APIs) and intermediates for pharmaceuticals, as well as raw materials for agrochemicals. It also manufactures fine chemical products and intermediates for electronic materials. The company focuses on providing customized chemical solutions to its clients in the pharmaceutical, agricultural science, and specialty chemical sectors.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for KPX Life Science, detailing the date, location, and agenda items (such as financial statement approval, director/auditor appointments, and remuneration limits). This document serves as the official solicitation and notification for shareholders to attend and vote at the meeting, which aligns with the definition of Proxy Solicitation & Information Statement (PSI).
2022-03-08 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for KPX Life Science. It contains the meeting agenda, voting procedures, electronic voting information, and management reference materials (business overview, industry status, etc.) required by law for shareholders. This document is a standard proxy statement/notice package sent to shareholders to inform them of the upcoming AGM and solicit their votes, which falls under the Proxy Solicitation & Information Statement category.
2022-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains detailed information about the meeting agenda, director/auditor candidates, and proxy voting procedures. This falls under the 'Proxy Solicitation & Information Statement' category.
2022-03-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from KPX Life Science regarding a significant change in financial structure (revenue or profit/loss fluctuation of 30% or more). This is a standard disclosure requirement in the Korean market (DART system) for listed companies to announce material financial changes before the final audit report is published. Since it provides key financial highlights and reasons for the change rather than being a full annual report or a simple announcement of a report's availability, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial performance. FY 2021
2022-01-21 Korean
주주명부폐쇄기간또는기준일설정
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of the upcoming Annual General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal notification of a corporate action. Given it is a standard regulatory disclosure regarding shareholder rights and meeting preparation, it fits best under the RNS category.
2021-12-14 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for KPX Life Science, covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.